" "
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IONICON US Starts its Operations in North America

Published: Thursday, October 20, 2011
Last Updated: Wednesday, October 19, 2011
Bookmark and Share
Effective and fast local PTR-MS sales and support for US customers now directly available from IONICON US, Inc., New Jersey.

IONICON US, Inc. is a totally-owned subsidiary of Austrian-based IONICON Analytik GmbH, the world’s leading PTR-MS company since 1998. The new US subsidiary takes over the marketing and after-sales-support for the United States and Canada.

IONICON, a manufacturer of highest performance online mass spectrometers for VOC analysis based on the unique Proton Transfer Reaction - Mass Spectrometry technology (PTR-MS) and known for its superior customer support, will now increase its investment in the US market.

Co-founder of IONICON Austria and Vice-President of IONICON US, Inc. Dr. Alfons JORDAN recently moved to the US in order to start IONICON US. He is eager to turn his challenging assignment into success: “I will be the first point of contact for all inquiries from the US and I am looking forward to be in touch with all our US customers and people interested in our products. For demonstrations we have an IONICON High-Sensitivity PTR-MS available in a nearby lab which can be used for showcases and tests of samples.”

IONICON CEO Lukas MÄRK is looking forward to the start-up of operations at IONICON US: “This will improve the user experience as one of our most experienced PTR-MS experts is now residing in New Jersey and is available for inquiries, customer showcases and professional after-sales-service.”

Since the first sale of an IONICON PTR-MS to the US in 2000, more than 40 systems have been exported to IONICON’s most important market outside of Europe.

Lukas MÄRK comments on the company’s US strategy: “This investment will stimulate growth of our business in the United States, help customers to build confidence in our innovative and successful but relatively small company by showing our local presence and dedication to the United States”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Thursday, August 20, 2015
IONICON Selects RJ Lee Group as Exclusive U.S. Distributor
RJ Lee Group has become the exclusive U.S. distribution partner for IONICON’s Trace Gas Analysis products.
Thursday, June 27, 2013
World’s Leading PTR-MS Company IONICON Integrates its Subsidiary
IONICON to celebrate its 15th anniversary in July 2013.
Friday, June 07, 2013
RJ Lee Group's Mobile Lab is Now Deployed for Real-Time VOCs Monitoring
RJ Lee Group equipes mobile lab with IONICON PTR-MS and provides rapid, mobile monitoring of organic contamination and leaks caused by hurricane "Sandy".
Thursday, November 15, 2012
IONICON Announces New Distribution Partner for Australia and New Zealand
IONICON and Ecotech are teaming up.
Wednesday, August 22, 2012
IONICON Announces New Distribution Partner for Singapore, Malaysia and Thailand
IONICON and Omega join efforts in Southeast Asia.
Monday, April 30, 2012
First Results of CERN's CLOUD Experiment Published in NATURE
The CLOUD experiment has been designed to study the effect of cosmic rays on the formation of atmospheric aerosols under controlled laboratory conditions.
Thursday, August 25, 2011
IONICON Announces New Distribution Partner for India
IONICON and MARS Bioanalytical have teamed up to target the Indian market.
Sunday, July 24, 2011
IONICON Appoints New CEO
Mr. Lukas MÄRK stepped in as CEO IONICON Analytik GmbH on June 1, 2011.
Monday, July 11, 2011
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!